Literature DB >> 811159

Hospital Pseudomonas aeruginosa: surveillance of resistance to gentamicin and transfer of aminoglycoside R factor.

N Maliwan, H G Grieble, T J Bird.   

Abstract

Tube dilution susceptibility tests in Trypticase soy broth showed that resistance to gentamicin (minimum bactericidal concentration >==12.5 mug/ml) among hospital isolates of Pseudomonas aeruginosa increased from 13.9% in 1969 to 38.9% in 1972. Transfer of drug resistance to six aminoglycosides from one wild Pseudomonas strain to another was accomplished in recombination experiments. A carbenicillin-resistant, beta-lactamase-producing strain served as the recipient. The exconjugant was resistant not only to aminoglycosides, including amikacin, but also to all clinically employed antimicrobials. Aminoglycoside resistance in the exconjugant was cured by sodium dodecyl sulfate. This transferable aminoglycoside resistance was not mediated by adenylylation or, as judged by bioassay, by other antibiotic-inactivating or -modifying processes.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 811159      PMCID: PMC429359          DOI: 10.1128/AAC.8.4.415

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  32 in total

1.  R-factor mediated gentamicin resistance: A new enzyme which modifies aminoglycoside antibiotics.

Authors:  R Benveniste; J Davies
Journal:  FEBS Lett       Date:  1971-05-20       Impact factor: 4.124

2.  Episome-mediated transfer of drug resistance in Enterobacteriaceae. I. Transfer of resistance factors by conjugation.

Authors:  T WATANABE; T FUKASAWA
Journal:  J Bacteriol       Date:  1961-05       Impact factor: 3.490

3.  Transfer of gentamicin resistance from Pseudomonas aeruginosa strains highly resistant to gentamicin and carbenicillin.

Authors:  H Knothe; V Krcméry; W Sietzen; J Borst
Journal:  Chemotherapy       Date:  1973       Impact factor: 2.544

4.  [Evoution of gentamicin resistance].

Authors:  D Christol; A Bure; Y Boussougant; J Witchitz
Journal:  Presse Med       Date:  1971-02-27       Impact factor: 1.228

5.  Pseudomonas aeruginosa resistant to carbenicillin and gentamicin. Epidemiologic and clinical aspects in a cancer center.

Authors:  W H Greene; M Moody; S Schimpff; V M Young; P H Wiernik
Journal:  Ann Intern Med       Date:  1973-11       Impact factor: 25.391

6.  Effect of salt concentration on the apparent in-vitro susceptibility of Pseudomonas and other gram-negative bacilli to gentamicin.

Authors:  A A Medeiros; T F O'Brien; W E Wacker; N F Yulug
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

7.  Effect of the concentrations of magnesium and calcium on the in-vitro susceptibility of Pseudomonas aeruginosa to gentamicin.

Authors:  D N Gilbert; E Kutscher; P Ireland; J A Barnett; J P Sanford
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

8.  Cephalosporinase and penicillinase activities of a beta-lactamase from Pseudomonas pyocyanea.

Authors:  L D Sabath; M Jago; E P Abraham
Journal:  Biochem J       Date:  1965-09       Impact factor: 3.857

9.  Specific role of sex pili in the effective eliminatory action of sodium dodecyl sulfate on sex and drug resistance factors in Escherichia coli.

Authors:  H Adachi; M Nakano; M Inuzuka; M Tomoeda
Journal:  J Bacteriol       Date:  1972-03       Impact factor: 3.490

10.  Pyocine typing of clinical strains of Pseudomonas aeruginosa.

Authors:  R J Zabransky; F E Day
Journal:  Appl Microbiol       Date:  1969-02
View more
  4 in total

1.  Antimicrobial agent susceptibility patterns of bacteria in hospitals from 1971 to 1982.

Authors:  B A Atkinson; V Lorian
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

2.  Resistance to aminoglycoside antibiotics of gram-negative bacilli isolated in Canadian hospitals.

Authors:  I B Duncan; E Y Cheung; E V Haldane; F L Jackson; R D McNaughton; R A Morisset; M A Noble; R P Rennie; A R Ronald; J A Smith
Journal:  Can Med Assoc J       Date:  1981-05-01       Impact factor: 8.262

3.  Evidence for a chromosomal site specifying amikacin resistance in multiresistant Serratia marcescens.

Authors:  J F John; W F McNeill; K E Price; P A Kresel
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

4.  Ticarcillin in the treatment of experimental pseudomonas keratitis.

Authors:  A Ahmad; G Smolin; M Okumoto; S Ohno
Journal:  Br J Ophthalmol       Date:  1977-02       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.